Colon and rectal surgery, venous thromboembolism Surgery
Conditions
Interventions
Universal extended (30 days after surgery) prophylaxis with enoxaperin. Enoxaparin dose was weight based and used for 30 days after surgery. Survey was done 30 days after surgery.
Sponsors
Beth Israel Deaconess Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients undergoing colon and rectal surgery at BIDMC between 11/1/2017 and 10/31/2018
Exclusion criteria
Exclusion criteria: 1. Patients with contraindication for use of low molecular weight heparin 2. Patients already on anticoagulation for other conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Complications from extended use of enoxaparin, measured using chart review and phone interview at 30 days after surgery 2. Compliance with extended prophylaxis regimen, measured using phone survey at 30 days after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Rates of VTE measured using chart review and NSQIP data collection at 30 days after surgery 2. Other complications measured using chart review at 30 days after surgery | — |
Countries
United States of America
Outcome results
None listed